nafamostat has been researched along with Allergic Encephalomyelitis in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q | 1 |
| Nacion, K | 1 |
| Bu, H | 1 |
| Lin, F | 1 |
1 other study available for nafamostat and Allergic Encephalomyelitis
| Article | Year |
|---|---|
The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis.
Topics: Animals; Benzamidines; Complement C3-C5 Convertases; Encephalomyelitis, Autoimmune, Experimental; Fe | 2009 |